Company intelligence / Profile preview

Nordmark Pharma GmbH

Uetersen, Schleswig-Holstein, Germanynordmark-pharma.de ↗

Ownership: Private
Employees: ~700
Development stage: Commercial

Overview

Nordmark is a global leader in the production of pancreatin and collagenase, with FDA-approved manufacturing facilities and products marketed worldwide[5][8]

Therapeutic areas: GastroenterologyPulmonologyDermatology
Modalities: Biological active ingredientsenzymes (pancreatin, collagenase)proteins
Industry: Biotech

Drug pipeline

1 asset

Pankreatan

Unknown

Partnerships

Gemini Bio-Products (US distribution partner)[10]

Beyond the preview

Go deeper on Nordmark Pharma GmbH.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nordmark Pharma GmbH.

Explore the full profile